Radiotherapy in the management of synchronous metastatic lung cancer

Metastatic lung cancer classically portends a poor prognosis. The management of metastatic lung cancer has dramatically changed with the emergence of immune checkpoint inhibitors, targeted therapy and due to a better understanding of the oligometastatic process. In metastatic lung cancers, radiation therapy which was only used with palliative intent for decades, represents today a promising way to treat primary and oligometastatic sites with a curative intent. Herein we present through a literature review the role of radiotherapy in the management of synchronous metastatic lung cancers.

Published by Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2024. The guideline itself is at the source linked here.

doi.org/10.1016/j.canrad.2023.03.002